Meridian Wealth Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-17,000
| Closed | -$66K | – | 547 |
|
|
2022
Q4 | $66K | Sell |
17,000
-33,000
| -66% | -$128K | 0.01% | 515 |
|
|
2022
Q3 | $122K | Sell |
50,000
-30,000
| -38% | -$73.2K | 0.01% | 469 |
|
|
2022
Q2 | $158K | Sell |
80,000
-70,000
| -47% | -$138K | 0.01% | 520 |
|
|
2022
Q1 | $275K | Hold |
150,000
| – | – | 0.03% | 328 |
|
|
2021
Q4 | $212K | Sell |
150,000
-56,000
| -27% | -$79.1K | 0.02% | 376 |
|
|
2021
Q3 | $233K | Buy |
206,000
+42,000
| +26% | +$47.5K | 0.03% | 355 |
|
|
2021
Q2 | $262K | Buy |
164,000
+64,000
| +64% | +$102K | 0.03% | 321 |
|
|
2021
Q1 | $176K | Hold |
100,000
| – | – | 0.03% | 354 |
|
|
2020
Q4 | $195K | Buy |
100,000
+40,000
| +67% | +$78K | 0.03% | 322 |
|
|
2020
Q3 | $143K | Buy |
60,000
+40,000
| +200% | +$95.3K | 0.04% | 246 |
|
|
2020
Q2 | $58K | Buy |
+20,000
| New | +$58K | 0.02% | 222 |
|